JFK Communications was the global PR agency for S-1 (Teysuno) for the first-line treatment of advanced gastric cancer.  JFK Communications provided extensive global corporate and product public relations, including:

  • US and EU regulatory milestone support
  • Data communications
  • Media relations
  • Medical meeting support
  • KOL development and media training
  • Oncology Drugs Advisory Committee meeting support
  • Issues management
  • Advocacy relations 

Reach Out

Ready to tell your story?